W8.1_Introduction to Pharmacokinetics Flashcards

1
Q

Define pharmacokinetics. What are the clinical points of measurements in pharmacokinetics? What would be the basic questions of it?

A
  • Definition: what the body does to the drug
  • Clinical endpoints: measuring drug amount/concentration in biological spaces and fluids at specific time
  • Where, how much, when does the drug go?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

According to the cumulative amount of drug excreted versus time profile in urine or faeces, how can different drug concentrations in plasma be measured? What is the subsequent step?

A
  • Measuring drug concentration in plasma
  • LC-MS (liquid chromatography-mass spectrometry) for small molecule drugs
  • Immunoassay (ligand binding assay) for antibody drugs
  • After measuring -> calibration curve for quantification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

According to the pharmacokinetic profile, define therapeutic range, Cmax, Tmax, AUC, and t1/2. How can the route of administration be determined from it?

A
  • Therapeutic range: between MTC (maximum tolerated concentration) and MEC (minimum effective concentration)
  • Too low: no treatment effect vs too high: toxicity/ADR
  • Cmax: peak/maximum concentration (µg/mL)
  • Tmax: time required to reach Cmax (hr)
  • AUC: area under curve = total drug exposure across time (used to calculate bioavailability) (µg⋅h/mL)
  • t1/2: half-life is the time taken for drug concentration in plasma to reduce by half (used to determine distribution and elimination) (hr)
  • Route of administration can be determined by looking at the profile (X absorption? flat/steep? lag time?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the typical phases in a pharmacokinetic profile? Are there any exceptions? What is the use of pharmacokinetics in a clinical setting?

A
  • 0 -> onset time: absorption lag time
  • Onset time -> Tmax: absorption phase
  • Tmax -> 0: elimination phase
  • Exception: prolonged-release drugs (phases overlap and hard to distinguish)
  • Use of pharmacokinetics: dose adjustment for renal repairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Contrast pharmacokinetic and pharmacodynamic variabilities by giving examples.

A

Pharmacokinetic variability
- Compliance
- Dosing or medication errors
- Tissue and body fluid mass and volume
- Drug interactions
Pharmacodynamic variability
- Drug receptor status
- Genetic factors
- Drug interactions
- Tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly